Business Description
US Physical Therapy Inc
NAICS : 621498
SIC : 8093
ISIN : US90337L1089
Share Class Description:
USPH: Ordinary SharesDescription
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.62 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 3.32 | |||||
| Interest Coverage | 7.23 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.72 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EBITDA Growth Rate | -3.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2.8 | |||||
| 3-Year FCF Growth Rate | -1.9 | |||||
| 3-Year Book Growth Rate | 8.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.32 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.35 | |||||
| 9-Day RSI | 30.56 | |||||
| 14-Day RSI | 31.98 | |||||
| 6-1 Month Momentum % | 2.18 | |||||
| 12-1 Month Momentum % | 28.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.82 | |||||
| Quick Ratio | 2.82 | |||||
| Cash Ratio | 1.87 | |||||
| Days Sales Outstanding | 33.08 | |||||
| Days Payable | 4.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.87 | |||||
| Dividend Payout Ratio | 0.88 | |||||
| 3-Year Dividend Growth Rate | 12.9 | |||||
| Forward Dividend Yield % | 1.89 | |||||
| 5-Year Yield-on-Cost % | 3.18 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -2.34 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.26 | |||||
| Operating Margin % | 11.76 | |||||
| Net Margin % | 4.11 | |||||
| ROE % | 6.83 | |||||
| ROA % | 2.76 | |||||
| ROIC % | 7.03 | |||||
| ROC (Joel Greenblatt) % | 45.01 | |||||
| ROCE % | 8.16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 47.08 | |||||
| Forward PE Ratio | 31.13 | |||||
| PE Ratio without NRI | 47.08 | |||||
| Shiller PE Ratio | 39.86 | |||||
| Price-to-Owner-Earnings | 48.72 | |||||
| PEG Ratio | 15.19 | |||||
| PS Ratio | 2.09 | |||||
| PB Ratio | 2.79 | |||||
| Price-to-Free-Cash-Flow | 19.82 | |||||
| Price-to-Operating-Cash-Flow | 17.56 | |||||
| EV-to-EBIT | 22.99 | |||||
| EV-to-EBITDA | 18.59 | |||||
| EV-to-Forward-EBITDA | 17.71 | |||||
| EV-to-Revenue | 2.52 | |||||
| EV-to-Forward-Revenue | 2.29 | |||||
| EV-to-FCF | 24.05 | |||||
| Price-to-Projected-FCF | 1.23 | |||||
| Price-to-DCF (Earnings Based) | 3.95 | |||||
| Price-to-DCF (FCF Based) | 1.51 | |||||
| Price-to-Median-PS-Value | 0.9 | |||||
| Earnings Yield (Greenblatt) % | 4.35 | |||||
| Forward Rate of Return (Yacktman) % | 8.2 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:USPH
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
US Physical Therapy Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 580.778 | ||
| EPS (TTM) ($) | 1.93 | ||
| Beta | 1.45 | ||
| Volatility % | 39.95 | ||
| 14-Day RSI | 31.98 | ||
| 14-Day ATR ($) | 2.579277 | ||
| 20-Day SMA ($) | 94.367 | ||
| 12-1 Month Momentum % | 28.49 | ||
| 52-Week Range ($) | 76.555 - 124.11 | ||
| Shares Outstanding (Mil) | 14.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
US Physical Therapy Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
US Physical Therapy Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
US Physical Therapy Inc Frequently Asked Questions
What is US Physical Therapy Inc(USPH)'s stock price today?
The current price of USPH is $90.87. The 52 week high of USPH is $124.11 and 52 week low is $76.56.
When is next earnings date of US Physical Therapy Inc(USPH)?
The next earnings date of US Physical Therapy Inc(USPH) is 2023-11-03 Est..
Does US Physical Therapy Inc(USPH) pay dividends? If so, how much?
The Dividend Yield %  of US Physical Therapy Inc(USPH) is 1.87% (As of Today), Highest Dividend Payout Ratio of US Physical Therapy Inc(USPH) was 0.88. The lowest was 0.13. And the median was 0.44. The  Forward Dividend Yield % of US Physical Therapy Inc(USPH) is 1.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers